-
Part 2 | Session 5 Summary of Day One: Adrian Banning
-
Part 3 | Session 1 Drug Coated Balloons - A Solution Looking For a Problem?: Tuomas Rissanen
-
Part 3 | Session 2 Cage Fighting: PCI and the Post TAVI Population: Mark Spence
-
Part 4 | Session 1 Targeting Inflammation for Risk Reduction: Charalambos Antoniades
-
Part 4 | Session 3 Personalised Care through Technological Innovation: Nick West
-
Part 4 | Session 4 How Do I Protect Myself and Everyone in the Room: James Spratt
-
Part 4 | Session 6 Closing Comments: Adrian Banning
-
Part 1 | Session 1 Welcome and Course Objectives: Adrian Banning
-
Part 1 | Session 2 Using Physiology to Optimise Your Procedure: Sukh Nijjer
-
Part 1 | Session 3 Why I Adopted Intracoronary Imaging: Richard Bogle
-
Part 1 | Session 4 Learnings From Syntax 2 and FAME3: Adrian Banning
-
Part 2 | Session 1 CT Guided Intervention and 3D Reconstruction: Carlos Collet
-
Part 2 | Session 2 A Walkthrough Zero - or Minimal Contrast PCI: Ziad Ali
Millbrook Medical Conferences, in association with Abbott and Radcliffe Cardiology, proudly introduce the 6th annual CORE meeting, brought to you live and in person from the Royal College of Physicians, London.
CORE 2022 assembles world renowned experts to discuss and demonstrate how we can optimise PCI outcomes, together as a community. Innovative lectures and live cases address the appropriate treatment pathway for patients in 2022. We explore how to further improve patient outcomes by looking at the latest clinical evidence, cutting-edge techniques and beyond the intervention.
More from this programme
Part 1
CORE 2022 - Day 1: Morning - Imaging and Physiology
Part 2
CORE 2022 - Day 1: Afternoon - Pre-procedural Planning
Part 3
CORE 2022 - Day 2: Morning - Challenges in Complex PCI
Part 4
CORE 2022 - Day 2: Afternoon - Beyond Intervention
Faculty Biographies
Clare Appleby
Dr Clare Appleby is an interventional cardiologist at Liverpool Heart and Chest Hospital, Liverpool, UK. Trained in Wythenshawe and Blackpool, UK, Dr Appleby was awarded a BCIS Interventional Fellowship in Toronto, Canada. Her research interests include gene therapy for atherosclerosis and PCI outcomes. Dr Appleby has served as PI for several multi-centre PCI and TAVI trials. She has served as Honorary Secretary of the British Cardiovascular Intervention Society.